Healthy bodies, healthy lives

What's New

More

RSS

2014.07.23
Corporate
PDF/40KB
Sumitomo Dainippon Pharma announces Investment in a New Venture Capital Fund
2014.07.11
Products
PDF/168KB
Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy
2014.07.01
Others
 
"Corporate profile" An English version and a Japanese version are updated.
2014.06.30
Corporate
PDF/215KB
Transfer of Marketing Rights for “Inteban”, “Catlep” and “Drenison”
2014.06.24
Others
 
Posted Factbook 2014
2014.06.19
Corporate
PDF/181KB
Sumitomo Dainippon Pharma announces Change of the Company’s English trade name